Elekta Nomination Committee’s proposed Board of Directors for the 2015 Annual General Meeting

STOCKHOLM, July 1 – The Nomination Committee of Elekta AB (publ) (EKTA-B.ST)
proposes that the 2015 Annual General Meeting re-elect Board members Laurent
Leksell, Luciano Cattani, Siaou-Sze Lien, Wolfgang Reim, Jan Secher, Birgitta
Stymne Göransson and Tomas Puusepp, and elect Johan Malmqvist and Annika
Espander Jansson as directors of the Board. It is proposed that Laurent Leksell
be re-elected as Chairman of the Board. Hans Barella has declined re-election.
Annika Espander Jansson has 25 years’ experience as an analyst and investor, as
well as from executive positions within the financial markets and the
pharmaceutical industry. She is the founder of Asperia AB and has been the CEO
since June 2013. Annika Espander Jansson was born in 1964 and holds a BSc in
Chemistry from Uppsala University (Sweden)/University of Michigan, Ann Arbor
(US) and an MBA in International Business Management from Uppsala University.
From 2010 to 2013, she was Chief of Private Banking at Handelsbanken and also
Chairman of the Board of SHB Luxembourg; she has previously held executive
positions at, among other companies, Catella Healthcare/Esperio AB in Stockholm
and at Enskilda Securities. Annika Espander Jansson is a member of the Board of
Asperia AB, Esperio AB and Symphogen AS, and she has previous Board experience
from Biotage AB, Probi AB, Stille AB, Cellartis AB and SFF (Sveriges
Finansanalytikers Förening) among other companies.

Johan Malmqvist has extensive experience from the medical technology industry.
Johan Malmqvist was born in 1961 and holds a BA from Stockholm School of
Economics. From 1997 to 2015, he was president and CEO of Getinge AB. Before
that, he held various positions within the Getinge group and before joining
Getinge in 1990, Johan Malmqvist held several positions within the Electrolux
group. From 1997 to 2007, Johan Malmqvist was a member of the Board of Getinge
AB.

In accordance with the Nomination Committee’s proposal, the number of Board
members will thus be nine.

The Nomination Committee’s complete proposal for resolution at the Annual
General Meeting, to be held on September 1, 2015, will be available on the
company’s website and will be published in the notice of the Annual General
Meeting.

The Nomination Committee, prior to the 2015 Annual General Meeting, comprises
the following members: Laurent Leksell (Chairman), appointed by the Leksell
family for the family’s direct and indirect holdings and in his capacity as
Chairman of the Board, Åsa Nisell, appointed by Swedbank Robur Funds, Jens
Barnevik, appointed by Didner & Gerge Funds, Anders Oscarsson, appointed by AMF
and AMF Funds, and Ossian Ekdahl, appointed by Första AP-fonden. Caroline
Leksell Cooke has been co-opted to the Nomination Committee.

# # #

For further information, please contact:
Gert van Santen, Group Vice President Corporate Communications, Elekta AB
Tel: +31 653 561 242, e-mail: gert.vansanten@elekta.com
Time zone: CET: Central European Time

Johan Andersson, Director, Investor Relations, Elekta AB
Tel: +46 702 100 451, e-mail: johan.andersson@elekta.com
Time zone: CET: Central European Time
The above information is such that Elekta AB (publ) shall make public in
accordance with the Securities Market Act and/or the Financial Instruments
Trading Act. The information was published at 07:30 CET on July 1, 2015.
About Elekta
Elekta is a human care company pioneering significant innovations and clinical
solutions for treating cancer and brain disorders. The company develops
sophisticated, state-of-the-art tools and treatment planning systems for
radiation therapy, radiosurgery and brachytherapy, as well as workflow enhancing
software systems across the spectrum of cancer care. Stretching the boundaries
of science and technology, providing intelligent and resource-efficient
solutions that offer confidence to both health care providers and patients,
Elekta aims to improve, prolong and even save patient lives.
Today, Elekta solutions in oncology and neurosurgery are used in over 6,000
hospitals worldwide. Elekta employs around 3,800 employees globally. The
corporate headquarters is located in Stockholm, Sweden, and the company is
listed on NASDAQ Stockholm. Website: www.elekta.com.